{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-114136","form_type":"8-K","ticker":"IPSC","cik":"0001850119","company_name":"Century Therapeutics, Inc.","filed_at":"2024-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.047282+00:00","generated_at":"2026-05-30T05:29:09.251101+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Century Therapeutics Q3 net loss $31.2M; cash $244.7M, expands CNTY-101 autoimmune trial, 83% ORR in lymphoma","bullets":["Net loss $31.2M in Q3 2024; cash $244.7M; expects cash to support operations into H2 2026.","Expanded CNTY-101 autoimmune trial to include diffuse cutaneous systemic sclerosis and idiopathic inflammatory myopathy; basket protocol.","ELiPSE-1 interim: 83% ORR, 33% CRR at DL3B; no DLTs or high-grade CRS/ICANS; DL4B dosing initiated.","Strategic pipeline review to conclude Q1 2025; organizational restructuring extended cash runway.","Appointed Morgan Conn CFO and Chad Cowan CSO; Hy Levitsky transitioned to advisor."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-114136","json":"https://secwatch.observer/filing/0001104659-24-114136.json","markdown":"https://secwatch.observer/filing/0001104659-24-114136.md","text":"https://secwatch.observer/filing/0001104659-24-114136.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850119/000110465924114136/0001104659-24-114136-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850119/000110465924114136/tm2427432d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:29:09.251101+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}